Frank‐Michael C. Müller

2.1k total citations
29 papers, 1.6k citations indexed

About

Frank‐Michael C. Müller is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Frank‐Michael C. Müller has authored 29 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Infectious Diseases, 12 papers in Epidemiology and 9 papers in Molecular Biology. Recurrent topics in Frank‐Michael C. Müller's work include Antifungal resistance and susceptibility (21 papers), Fungal Infections and Studies (9 papers) and Bacterial biofilms and quorum sensing (6 papers). Frank‐Michael C. Müller is often cited by papers focused on Antifungal resistance and susceptibility (21 papers), Fungal Infections and Studies (9 papers) and Bacterial biofilms and quorum sensing (6 papers). Frank‐Michael C. Müller collaborates with scholars based in Germany, United States and Netherlands. Frank‐Michael C. Müller's co-authors include Marc Seidler, Stefanie Salvenmoser, Thomas J. Walsh, Miki Kasai, Andrea Francesconi, Stephen J. Chanock, Anne Beauvais, Michael Weig, Anselm Petschelt and Ulrich Lohbauer and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Frank‐Michael C. Müller

29 papers receiving 1.5k citations

Peers

Frank‐Michael C. Müller
Soňa Kucharíková Belgium
Neena Jain United States
Hironobu Koga Japan
Beyza Ener Türkiye
J. Chandra United States
Josep M. Sierra Spain
Natalie J. Garton United Kingdom
Marı́a D. Moragues Spain
Hiram Sánchez United States
Yvonne R. Shea United States
Soňa Kucharíková Belgium
Frank‐Michael C. Müller
Citations per year, relative to Frank‐Michael C. Müller Frank‐Michael C. Müller (= 1×) peers Soňa Kucharíková

Countries citing papers authored by Frank‐Michael C. Müller

Since Specialization
Citations

This map shows the geographic impact of Frank‐Michael C. Müller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank‐Michael C. Müller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank‐Michael C. Müller more than expected).

Fields of papers citing papers by Frank‐Michael C. Müller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank‐Michael C. Müller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank‐Michael C. Müller. The network helps show where Frank‐Michael C. Müller may publish in the future.

Co-authorship network of co-authors of Frank‐Michael C. Müller

This figure shows the co-authorship network connecting the top 25 collaborators of Frank‐Michael C. Müller. A scholar is included among the top collaborators of Frank‐Michael C. Müller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank‐Michael C. Müller. Frank‐Michael C. Müller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Müller, Frank‐Michael C., Marc Seidler, & Anne Beauvais. (2011). Aspergillus fumigatusbiofilms in the clinical setting. Medical Mycology. 49(S1). S96–S100. 95 indexed citations
2.
Müller, Frank‐Michael C. & Marc Seidler. (2010). Characteristics of pathogenic fungi and antifungal therapy in cystic fibrosis. Expert Review of Anti-infective Therapy. 8(8). 957–964. 30 indexed citations
3.
Seidler, Marc, Stefanie Salvenmoser, & Frank‐Michael C. Müller. (2010). Liposomal amphotericin B eradicates Candida albicans biofilm in a continuous catheter flow model. FEMS Yeast Research. 10(4). 492–495. 24 indexed citations
4.
Hebestreit, Alexandra, et al.. (2010). Persistence ofCandidaspecies in the respiratory tract of cystic fibrosis patients. Medical Mycology. 48(1). 56–63. 51 indexed citations
5.
Bruns, Sandra, Marc Seidler, Daniela Albrecht, et al.. (2010). Functional genomic profiling of Aspergillus fumigatus biofilm reveals enhanced production of the mycotoxin gliotoxin. PROTEOMICS. 10(17). 3097–3107. 68 indexed citations
6.
Valk, Hanneke A. de, Corné H. W. Klaassen, J.L. Yntema, et al.. (2008). Molecular typing and colonization patterns of Aspergillus fumigatus in patients with cystic fibrosis. Journal of Cystic Fibrosis. 8(2). 110–114. 42 indexed citations
7.
Lohbauer, Ulrich, Frank‐Michael C. Müller, & Anselm Petschelt. (2007). Influence of surface roughness on mechanical strength of resin composite versus glass ceramic materials. Dental Materials. 24(2). 250–256. 83 indexed citations
8.
Eichinger, Monika, Michael Puderbach, Christian Fink, et al.. (2006). Contrast-enhanced 3D MRI of lung perfusion in children with cystic fibrosis—initial results. European Radiology. 16(10). 2147–2152. 81 indexed citations
9.
Seidler, Marc, Stefanie Salvenmoser, & Frank‐Michael C. Müller. (2006). In vitro effects of micafungin against Candida biofilms on polystyrene and central venous catheter sections. International Journal of Antimicrobial Agents. 28(6). 568–573. 52 indexed citations
10.
Puderbach, Michael, Monika Eichinger, Sebastian Ley, et al.. (2006). Proton MRI appearance of cystic fibrosis: Comparison to CT. European Radiology. 17(3). 716–724. 87 indexed citations
11.
Ley, Sebastian, Michael Puderbach, Christian Fink, et al.. (2005). Assessment of hemodynamic changes in the systemic and pulmonary arterial circulation in patients with cystic fibrosis using phase-contrast MRI. European Radiology. 15(8). 1575–1580. 30 indexed citations
12.
Gil‐Lamaignere, Cristina, et al.. (2005). Effect of media composition and in vitro activity of posaconazole, caspofungin and voriconazole against zygomycetes. Journal of Antimicrobial Chemotherapy. 55(6). 1016–1019. 24 indexed citations
13.
Zhu, Liping, Cristina Gil‐Lamaignere, & Frank‐Michael C. Müller. (2004). Effects of several antifungal drug combinations against clinical and environmental isolates of Cryptococcus neoformans from China. Mycoses. 47(7). 319–325. 9 indexed citations
14.
Müller, Frank‐Michael C., A. Trusen, & Michael Weig. (2002). Clinical manifestations and diagnosis of invasive aspergillosis in immunocompromised children. European Journal of Pediatrics. 161(11). 563–574. 31 indexed citations
15.
Zepelin, Margarete Borg‐von, et al.. (2002). Effect of Micafungin (FK463) on <i>Candida albicans</i> Adherence to Epithelial Cells. Chemotherapy. 48(3). 148–153. 19 indexed citations
16.
Anaissie, Elias, John Rex, Andrea Francesconi, et al.. (2001). Fusariosis Associated with Pathogenic Fusarium Species Colonization of a Hospital Water System: A New Paradigm for the Epidemiology of Opportunistic Mold Infections. Clinical Infectious Diseases. 33(11). 1871–1878. 235 indexed citations
17.
Müller, Frank‐Michael C., Joachim Morschhäuser, Gerwald A. Köhler, et al.. (1999). Adhärenz und Invasion: Zwei Pathogenitätsfaktoren bei pathogenen Bakterien und Pilzen: Adherence and invasion – two pathogenicity factors in bacterial and fungal pathogens. Mycoses. 42(S1). 39–42. 5 indexed citations
18.
Groll, Andreas H., Frank‐Michael C. Müller, Stephen C. Piscitelli, & Thomas J. Walsh. (1998). Lipid formulations of Amphotericin B: Clinical perspectives for the management of invasive fungal infections in children with cancer. Klinische Pädiatrie. 210(4). 264–273. 20 indexed citations
19.
Müller, Frank‐Michael C., et al.. (1998). Rapid Extraction of Genomic DNA from Medically Important Yeasts and Filamentous Fungi by High-Speed Cell Disruption. Journal of Clinical Microbiology. 36(6). 1625–1629. 133 indexed citations
20.
Dreyfus, Marie, Margaret Masterson, Michéle David, et al.. (1995). Replacement Therapy with a Monoclonal Antibody Purified Protein C Concentrate in Newborns with Severe Congenital Protein C Deficiency. Seminars in Thrombosis and Hemostasis. 21(4). 371–381. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Soňa Kucharíková Breakdown of academic impact, for papers by Neena Jain Breakdown of academic impact, for papers by Hironobu Koga Breakdown of academic impact, for papers by Beyza Ener Breakdown of academic impact, for papers by J. Chandra Breakdown of academic impact, for papers by Josep M. Sierra Breakdown of academic impact, for papers by Natalie J. Garton Breakdown of academic impact, for papers by Marı́a D. Moragues Breakdown of academic impact, for papers by Hiram Sánchez Breakdown of academic impact, for papers by Yvonne R. Shea
Rankless by CCL
2026